Assenagon Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-112,487
| Closed | -$1.58M | – | 1426 |
|
|
2024
Q1 | $1.58M | Sell |
112,487
-51,931
| -32% | -$728K | ﹤0.01% | 932 |
|
|
2023
Q4 | $1.39M | Sell |
164,418
-24,613
| -13% | -$209K | ﹤0.01% | 990 |
|
|
2023
Q3 | $1.69M | Buy |
189,031
+50,330
| +36% | +$450K | 0.01% | 889 |
|
|
2023
Q2 | $1.2M | Buy |
138,701
+94,468
| +214% | +$815K | ﹤0.01% | 901 |
|
|
2023
Q1 | $466K | Buy |
44,233
+24,282
| +122% | +$256K | ﹤0.01% | 1188 |
|
|
2022
Q4 | $676K | Hold |
19,951
| – | – | ﹤0.01% | 1074 |
|
|
2022
Q3 | $958K | Hold |
19,951
| – | – | ﹤0.01% | 919 |
|
|
2022
Q2 | $1.14M | Buy |
19,951
+19,026
| +2,057% | +$1.08M | ﹤0.01% | 1011 |
|
|
2022
Q1 | $75K | Hold |
925
| – | – | ﹤0.01% | 1336 |
|
|
2021
Q4 | $187K | Buy |
+925
| New | +$187K | ﹤0.01% | 1333 |
|
|
2020
Q4 | – | Sell |
-13,097
| Closed | -$3.26M | – | 1136 |
|
|
2020
Q3 | $3.26M | Buy |
+13,097
| New | +$3.26M | 0.02% | 438 |
|
|
2019
Q2 | – | Sell |
-5,834
| Closed | -$2.94M | – | 1064 |
|
|
2019
Q1 | $2.94M | Sell |
5,834
-1,308
| -18% | -$659K | 0.03% | 380 |
|
|
2018
Q4 | $3.52M | Buy |
+7,142
| New | +$3.52M | 0.04% | 269 |
|